ECRG2 enhances the anti-cancer effects of cisplatin in cisplatin-resistant esophageal cancer cells via upregulation of p53 and downregulation of PCNA

por Hou, Xin-Fang, Xu, Lin-Ping, Song, Hai-Yan, Li, Shuai, Wu, Chen, Wang, Ju-Feng
Publicado 2017

Effect of ECRG2 in combination with cisplatin on the proliferation and apoptosis of EC9706 cells

por SONG, HAI-YAN, DENG, XIAO-HUI, HOU, XIN-FANG, YUAN, GUO-YAN, ZHU, ZHEN-DONG, REN, MING-XIN
Publicado 2014